NCT07546188
- Conditions
- Care Coordination, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Grand Hôpital de Charleroi Charleroi, Hainaut, Belgium
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,951 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
Recruiting
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
NCT03523975
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- City of Hope Medical center Duarte, California, United States
- University of Michigan Ann Arbor, Michigan, United States
- The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Virginia Cancer Center Charlottesville, Virginia, United States
Recruiting
Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
NCT07545603
- Conditions
- Follicular Lymphoma Grade 3A, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, +11 more
- Locations
-
- Beijing Cancer Hospitial Beijing, Beijing Municipality, China
NCT06839053
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +25 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT05858424
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Centre Leon Berard Lyon, France
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- GSK Investigational Site Mobile, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Pasadena, California, United States
NCT03823534
- Conditions
- Blood Protein Disorders, Bone Metastases, Cardiovascular Diseases, +23 more
- Locations
-
- Saint Louis University St Louis, Missouri, United States
NCT02974647
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
- Northwestern Medicine (Data collection and specimen analysis) Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
NCT05972135
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +18 more
- Locations
-
- Arizona Oncology Associates Tucson, Arizona, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- Medical Oncology Hematology Consultants Newark, Delaware, United States
NCT07085039
- Conditions
- Castleman Disease, Castleman's Disease (CD), Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States